2nd Quarter - Report

CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.) for COMPLETE GENOMICS, INC.

Firm
Client
Income
$180,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).

LobbyistCovered position, as disclosed
BRIAN BERRY —
ROBERT A CHLOPAK —
NATALIE PAVLATOS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7085 (118th)

Medical/Disease Research/Clinical Labs MED

BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).

LobbyistCovered position, as disclosed
BRIAN BERRY —
ROBERT A CHLOPAK —
NATALIE PAVLATOS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7085 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.